Related Experiment Video
Updated: Apr 26, 2026
07:30
Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
4.0K
Robotic nephron-sparing surgery for renal tumors: Current status
Raed A Azhar1, Inderbir S Gill2, Monish Aron2
1Catherine and Joseph Aresty Department of Urology, USC Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA ; Department of Urology, King Abdulaziz University, Jeddah, Saudi Arabia.
Summary
Robotic partial nephrectomy (RPN) offers a viable alternative to traditional methods for kidney tumors, demonstrating excellent short-term results. Ongoing advancements continue to refine RPN techniques and expand its applications in urologic surgery.
Area of Science:
- Urologic oncology
- Minimally invasive surgery
- Robotic surgery
Background:
- Robotic partial nephrectomy (RPN) has emerged as a significant advancement in treating renal masses.
- Traditional open and laparoscopic partial nephrectomy have been the standard of care.
- The evolution of robotic technology has enabled new approaches to kidney-sparing surgery.
Purpose of the Study:
- To review recent advances in robotic partial nephrectomy (RPN).
- To emphasize the evolution of RPN techniques and patient outcomes.
- To discuss the expanding indications for RPN in managing renal masses.
Main Methods:
- A comprehensive literature review was conducted using the National Library of Medicine database.
- English-language articles focusing on RPN were identified and analyzed.
- Citations from relevant articles were used to broaden the search for additional pertinent studies.
Main Results:
- RPN is an evolving procedure and a viable alternative to laparoscopic and open partial nephrectomy.
- Contemporary RPN techniques yield excellent perioperative outcomes.
- Short-term oncologic outcomes of RPN are comparable to traditional surgical approaches.
Conclusions:
- Robotic partial nephrectomy demonstrates favorable perioperative and short-term oncologic outcomes.
- Further research is necessary to evaluate the long-term oncologic control offered by RPN.
- RPN represents a significant development in minimally invasive treatment for renal masses.
